Filing Details

Accession Number:
0001354488-15-004685
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-10-21 21:27:02
Reporting Period:
2015-10-21
Filing Date:
2015-10-21
Accepted Time:
2015-10-21 21:27:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1378624 Cellular Biomedicine Group Inc. CBMG Biological Products, (No Disgnostic Substances) (2836) 861032927
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1569877 K Andrew Chan 19925 Stevens Creek Blvd., Suite 100
Cupertino CA 95014
No No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-10-19 1,516 $5.61 163,712 No 4 M Direct
Common Stock Disposition 2015-10-19 1,516 $20.50 162,196 No 4 S Direct
Common Stock Disposition 2015-10-19 2,403 $20.50 159,793 No 4 S Direct
Common Stock Acquisiton 2015-10-20 1,296 $3.00 161,089 No 4 M Direct
Common Stock Disposition 2015-10-20 1,296 $19.30 159,793 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non- Qualified Stock Option (right to buy) (2013 Plan) Disposition 2015-10-19 1,516 $0.00 1,516 $5.61
Common Stock Non-Qualified Stock Option (right to buy) (2011 Plan) Disposition 2015-10-20 1,296 $0.00 1,296 $3.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
43,968 2024-05-16 No 4 M Direct
44,075 2023-02-20 No 4 M Direct
Footnotes
  1. The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2015. Accordingly, the reporting person had no discretion with regard to the timing of the transaction.
  2. The option vested according to the following schedule: 1/31st per month following the vesting commencement date of May 16, 2014.
  3. The option vested according to the following schedule: 1/36th per month following the vesting commencement date of February 20, 2013.